David R. Rosenberg, M.D.

In this presentation, Dr. David Rosenberg discusses tic disorders in children and adolescents, including an in-depth analysis of how to make a correct diagnosis, common differential diagnoses, and frequent comorbid conditions. Additionally, he discusses the clinical management of tic disorders, addressing behavioral and pharmacologic treatments. At the end of the presentation, he highlights essential clinical pearls through a case example.

In this presentation, Dr. David Rosenberg discusses the use of complementary and alternative medicines (CAMs) in children and adolescents. He reviews the available evidence and potential indications of the most used CAMs in children with mental health conditions, such as melatonin, ginkgo biloba, ginseng, and St. John’s wort. Additionally, he provides prescription and monitoring guidelines for these medications. At the end of the presentation, he provides a clinical vignette to elucidate the use of CAM therapies in clinical practice.

In this presentation, Dr. David Rosenberg discusses the use of atypical psychopharmacologic strategies in children and adolescents. He reviews potential indications of nonstandard psychoactive drugs, such as opiate antagonists, glutamate modulators, anticonvulsants, and exogenous hormones, providing prescription and monitoring guidelines for these medications. At the end of the presentation, he highlights valuable concepts with a clinical vignette.

In this presentation, Dr. David Rosenberg discusses psychosis and schizophrenia in children and adolescents, including unique features, differential diagnoses, and the importance of assessing psychotic symptoms in childhood. He reviews treatment considerations for this particular population, with a primary focus on the use of antipsychotics and psychosocial interventions. Additionally, he provides clinical insights and a vignette to illustrate the challenges of using antipsychotics in children.

In this presentation, Dr. David Rosenberg discusses obsessive-compulsive disorder in children and adolescents, including unique features of pediatric OCD, common differential diagnoses, and frequent comorbid conditions. He also provides management guidelines, including appropriate CBT and SSRI treatment optimization, together with augmentation strategies for treatment-resistant patients. At the end of the presentation, he highlights essential clinical pearls using a sample case.